“Our expertise to develop your growth projects”
Because of their size and their European and worldwide visibility, the major pharmaceutical markets like France, United Kingdom and Germany provide an attractive space for the development of companies. Several factors contribute to this dynamic, such as the emergence of many healthcare companies (start-up, biotech, etc.), the efforts of the governments to promote access to the latest generation healthcare, or emerging needs and services, notably due to the population ageing.
However, environment remains challenging and requires rolling out a local economic, regulatory and market access expertise. Business development requires a strategic business approach involving a sound knowledge of the sector and its challenges.
The identification of new capitalistic and commercial opportunities is in line with the objective of creating sustainable business value in-house or through partner networks.
For more than 15 years, Nextep has been providing support to senior managers of particularly innovative international firms using the additional expertise of a team of dedicated consultants and high-level experts who sit in our Advisory and Medical Boards and who can mobilize an exceptional network of key contacts in the healthcare sector.
These complementary skills and experiences enable us to advise our customers in their most strategic decisions and to effectively promote their acquisition, partnership and development projects in Europe and on the international scene.